
Trump Administration Temporarily Halts Health Agency Communications from CDC, FDA, and NIH
A temporary pause on communications from major federal health agencies has been implemented under orders from the Trump administration. This affects the CDC, FDA, and NIH's public communications, including reports, announcements, and social media posts.

Trump at White House desk
The pause, announced by Acting HHS Secretary Dorothy Fink, will remain in effect until political appointees can review and approve agency communications. While such pauses are common during presidential transitions, they typically occur during the transition period rather than post-inauguration.
Key effects of the pause include:
- Suspension of Federal Register communications
- Halt on CDC's Morbidity and Mortality Weekly Report (MMWR)
- Temporary stop on NIH grant reviews and council meetings
- Restrictions on social media and website updates
Exceptions will be made for communications involving:
- Critical health matters
- Safety concerns
- Environmental issues
- Financial impacts
- National security functions
Healthcare experts have expressed mixed reactions. While some understand the need for review during administration changes, others worry about potential public health implications. Dr. Richard Besser, former acting CDC director, emphasized that pausing CDC communications could put public health at risk by preventing healthcare professionals from doing their jobs effectively.
The FDA continues to maintain its recall list and post critical drug warnings, demonstrating that essential public health communications will continue. The pause is expected to last until the end of January, allowing the new administration to establish review processes for federal health agency communications.
Current operations at the NIH have been significantly impacted, affecting grant reviews, council meetings, and research funding decisions. This has created uncertainty in academic medical centers and among study participants in NIH-funded trials.
The HHS maintains that this is a short-term measure to allow the new team to establish proper review processes, with critical health communications continuing on a case-by-case basis.
Related Articles

Study Shows Vaping Makes Quitting Smoking Harder, Not Easier
